secwatch.observer — SEC 8-K summary
======================================

Issuer:     GYRE THERAPEUTICS, INC. (GYRE)
CIK:        0001124105
Form:       8-K
Filed at:   2024-03-21T23:59:59+00:00
Accession:  0001140361-24-014493
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gyre Therapeutics appoints Rodney Nussbaum to Board and Audit Committee
-----------------------------------------------------------------------

- Rodney Nussbaum appointed Class III director effective March 20, 2024; joins Audit Committee.
- Nussbaum is a retired CPA with 40 years at Ernst & Young, KPMG, and Arthur Andersen.
- Currently Managing Executive of Atago Advisory, LLC, an accounting advisory firm.
- Compensation per non-employee director policy; enters standard indemnification agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1124105/000114036124014493/0001140361-24-014493-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1124105/000114036124014493/ef20024709_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-014493

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer